首页> 外国专利> The recombinant protein DMA-CBD, its production method, a recombinant plasmid pDMA-CBD and the strain E. coli M15 for its preparation, an injectable drug to increase muscle mass of farm animals, birds and animals canines, as well as the method of use of the drug

The recombinant protein DMA-CBD, its production method, a recombinant plasmid pDMA-CBD and the strain E. coli M15 for its preparation, an injectable drug to increase muscle mass of farm animals, birds and animals canines, as well as the method of use of the drug

机译:重组蛋白DMA-CBD,其生产方法,重组质粒pDMA-CBD和其制备用的大肠杆菌M15菌株,可增加家畜,鸟类和动物犬肌肉质量的可注射药物以及该方法药物的使用

摘要

1. Recombinant protein DMA-CBD with a molecular weight (25,73 ± 1000) Yes pI 5,05, DMA protein comprising a fragment of sequence SEQ ID NO 1, Gly-Ser spacer to SEQ ID NO 2 sequence tsellyulozosvyazuyuschy domain endoglucanase gene CelD from A. thermophilum sequence with SEQ ID NO 4.2. The process for producing DMA-CBD on the cellulose recombinant protein comprising: growing cells of the strain E. coli M15 [pREP4, pDMA-CBD], DMA-CBD binding protein in cell extracts of E. coli M15 [pREP4, pDMA-CBD] Cellulosic sorbent due affinity interactions by incubation procedure, subsequent washing of unbound bacterial proteins ivydelenie produkta.3 target. The recombinant plasmid pDMA-CBD with the nucleotide sequence SEQ ID NO 4 provides DMA-CBD expression of a recombinant protein consisting of A determinants myostatin, Gly-Ser spacer domain endoglucanase gene tsellyulozosvyazuyuschego CelD from Anaerocellum thermophilum (A. thermophilum), size of 4091 n. n, consisting of the following structural elements: a. an artificial bacterial operon DMA-CBD recombinant protein comprising the promoter region of an early promoter of bacteriophage T5 7-87 bp DMA-CBD gene recombinant protein 115-813 bp nontranslated termination region trance RTOC 1693-1791 bp bacterial operon beta-lactamase, providing resistance to ampicillin 3886-3029 bp complementary strand, a bacterial origin of replication site type ColE1 2263-2273 bp provides plasmid replication in strains of E. coli.4. The strain of E. coli M15 [pREP4, pDMA-CBD], obtained by transformation with the plasmid of claim 3, deposited in the Russian Collection of Microorganisms under number VKM B-2880D.5. The injection for increasing muscle mass of farm animals, poultry and animals canine containing the recombinant protein DMA-CBD of claim 1, suspended in a medium of amorphous cellulose to 90% by weight, acceptably
机译:1.分子量(25,73±1000)的重组蛋白DMA-CBD是pI 5,05,包含SEQ ID NO 1序列的片段的DMA蛋白,Gly-Ser间隔区与SEQ ID NO 2序列tsellyulozosvyazuyuschy域内切葡聚糖酶基因来自嗜热气单胞菌序列的CelD,其具有SEQ ID NO 4.2。在纤维素重组蛋白上产生DMA-CBD的方法包括:在大肠杆菌M15 [pREP4,pDMA-CBD]的细胞提取物中生长大肠杆菌M15菌株的细胞[pREP4,pDMA-CBD],DMA-CBD结合蛋白。 ]纤维素吸附剂通过亲和力相互作用通过孵育程序,随后洗涤未结合的细菌蛋白ivydelenie produkta.3目标。具有核苷酸序列SEQ ID NO 4的重组质粒pDMA-CBD提供了重组蛋白的DMA-CBD表达,该重组蛋白由A决定簇肌生长抑制素,Gly-Ser间隔域内切葡聚糖酶基因tsellyulozosvyazuyuschego CelD得自嗜热厌氧杆菌(A. thermophilum),大小为4091 。 n,由以下结构元素组成:一种人工细菌操纵子DMA-CBD重组蛋白,其包含噬菌体T5的早期启动子的启动子区域7-87 bp DMA-CBD基因重组蛋白115-813 bp非翻译终止区域tr RTOC 1693-1791 bp细菌操纵子β-内酰胺酶,提供对氨苄青霉素3886-3029 bp互补链的抗性,一种细菌复制位点类型ColE1 2263-2273 bp,可在大肠杆菌菌株中提供质粒复制.4。通过用权利要求3的质粒转化获得的大肠杆菌M15菌株[pREP4,pDMA-CBD],以VKM B-2880D.5保藏在俄罗斯微生物收藏中。 6.用于增加农场动物,家禽和动物犬的肌肉质量的注射剂,其包含权利要求1的重组蛋白DMA-CBD,其悬浮于无定形纤维素的培养基中至90重量%,可接受

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号